The PE Ratio as of November 2024 (TTM) for Oxford Nanopore Technologies plc (ONTTF) is -7.08

According to Oxford Nanopore Technologies plc’s latest financial reports and current stock price. The company's current PE Ratio is -7.08. This represents a change of 2.00% compared to the average of -6.94 of the last 4 quarters.

Oxford Nanopore Technologies plc (ONTTF) Historical PE Ratio (quarterly & annually)

How has ONTTF PE Ratio performed in the past?

The mean historical PE Ratio of Oxford Nanopore Technologies plc over the last ten years is -57.35. The current -7.08 PE Ratio has changed 1.13% with respect to the historical average. Over the past ten years (40 quarters), ONTTF's PE Ratio was at its highest in in the December 2023 quarter at -5.09. The PE Ratio was at its lowest in in the September 2020 quarter at -132.01.

Oxford Nanopore Technologies plc (ONTTF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Oxford Nanopore Technologies plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Oxford Nanopore Technologies plc (ONTTF) Average PE Ratio

How has ONTTF PE Ratio performed in the past?

The current PE Ratio of Oxford Nanopore Technologies plc (ONTTF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Oxford Nanopore Technologies plc (ONTTF) PE Ratio vs. Peers

How is ONTTF’s PE Ratio compared to its peers?

Oxford Nanopore Technologies plc’s PE Ratio is less than AgeX Therapeutics, Inc. (0), less than Lineage Cell Therapeutics, Inc. (-1.48), less than Cadrenal Therapeutics, Inc. Common Stock (-4.73), less than ImmuCell Corporation (-2.18), less than Reunion Neuroscience Inc. (-0.04), less than Braxia Scientific Corp. (-0.28), less than Algernon Pharmaceuticals Inc. (-0.69), less than Awakn Life Sciences Corp. (-0.74), less than Innovent Biologics, Inc. (-1.75), greater than Genscript Biotech Corporation (-44.50), less than Nuvalent, Inc. (0), greater than Nurix Therapeutics, Inc. (-16.36), greater than Seer, Inc. (-27.80), greater than Quantum-Si incorporated (-9.07), less than HCW Biologics Inc. (-1.80), less than MediciNova, Inc. (-2.57), less than null (-0.78), less than null (-0.04),

Build a custom stock screener for Oxford Nanopore Technologies plc (ONTTF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oxford Nanopore Technologies plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oxford Nanopore Technologies plc (ONTTF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oxford Nanopore Technologies plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.